BACKGROUND: The risk of developing esophageal adenocarcinoma (EAC) for patients with Barrett's esophagus (BE) is approximately 0.5% per year. OBJECTIVE: To investigate how patients with BE estimate and perceive their risk of developing EAC. DESIGN: Questionnaire study. SETTING: Patients with BE who were undergoing surveillance endoscopy based on histologic and flow cytometric results. PATIENTS: A total of 192 patients with BE were included. MAIN OUTCOME MEASUREMENTS: Individual patients were asked to estimate the numerical risk to develop EAC for patients with BE in general and for themselves. How patients perceived their own risk was measured on a scale from "very small" to "very large." RESULTS: At least 1 question was filled out by 169 patients (88% response). Sixty percent of respondents underestimated the numerical risk for patients with BE, in general, to develop EAC, while even more patients (69%) underestimated their own risk. Most respondents perceived their own risk as very small or small (63%). LIMITATIONS: Risk estimations may depend on the response scale used. CONCLUSIONS: Most patients with BE underestimated the numerical risk and perceived their risk of developing EAC as (very) low. Despite a low perceived risk, all patients in this group adhered to endoscopic surveillance.
BACKGROUND: The risk of developing esophageal adenocarcinoma (EAC) for patients with Barrett's esophagus (BE) is approximately 0.5% per year. OBJECTIVE: To investigate how patients with BE estimate and perceive their risk of developing EAC. DESIGN: Questionnaire study. SETTING:Patients with BE who were undergoing surveillance endoscopy based on histologic and flow cytometric results. PATIENTS: A total of 192 patients with BE were included. MAIN OUTCOME MEASUREMENTS: Individual patients were asked to estimate the numerical risk to develop EAC for patients with BE in general and for themselves. How patients perceived their own risk was measured on a scale from "very small" to "very large." RESULTS: At least 1 question was filled out by 169 patients (88% response). Sixty percent of respondents underestimated the numerical risk for patients with BE, in general, to develop EAC, while even more patients (69%) underestimated their own risk. Most respondents perceived their own risk as very small or small (63%). LIMITATIONS: Risk estimations may depend on the response scale used. CONCLUSIONS: Most patients with BE underestimated the numerical risk and perceived their risk of developing EAC as (very) low. Despite a low perceived risk, all patients in this group adhered to endoscopic surveillance.
Authors: M Hinojosa-Lindsey; J Arney; S Heberlig; J R Kramer; R L Street; H B El-Serag; A D Naik Journal: Dis Esophagus Date: 2013-02-05 Impact factor: 3.429
Authors: Mirjam Cm van der Ende-van Loon; Wilda D Rosmolen; Saskia Houterman; Erik J Schoon; Wouter L Curvers Journal: United European Gastroenterol J Date: 2018-09-07 Impact factor: 4.623
Authors: Jennifer R Kramer; Jennifer Arney; John Chen; Peter Richardson; Zhigang Duan; Richard L Street; Marilyn Hinojosa-Lindsey; Aanand D Naik; Hashem B El-Serag Journal: BMC Health Serv Res Date: 2012-08-28 Impact factor: 2.655
Authors: Michelle E Kruijshaar; Marie-Louise Essink-Bot; Bas Donkers; Caspar W N Looman; Peter D Siersema; Ewout W Steyerberg Journal: BMC Med Res Methodol Date: 2009-05-19 Impact factor: 4.615
Authors: James Britton; Paraskevi Taxiarchi; Glen Martin; Robert Willert; Maria Horne; Shaheen Hamdy; John McLaughlin; Yeng Ang Journal: BMJ Open Gastroenterol Date: 2020-03-31